Journal of Neurotrauma, 2023 · DOI: 10.1089/neu.2022.0500 · Published: December 1, 2023
This study examines the immune system changes in individuals with spinal cord injury (SCI) during the first year after their injury. It looks at RNA, protein, and cell profiles in blood samples to understand how the immune system changes over time compared to uninjured individuals. The researchers found that there are significant differences in gene expression related to immune function between individuals with SCI and those without, particularly affecting natural killer (NK) cells, monocytes, dendritic cells and T cells. The study also found that the severity of the spinal cord injury (whether it's a complete or incomplete motor injury) correlates with distinct gene expression profiles in the blood, indicating a persistent 'neurogenic' effect on the immune system.
The identified molecular and cellular changes may provide potential targets for therapeutic interventions aimed at reducing inflammation and improving immunity in individuals with SCI.
The study suggests candidate biomarkers of injury severity that could be used to monitor disease progression and treatment response.
Gene expression profiling may be used in a precision medicine approach to inform clinical trials in SCI, testing therapies that target specific immune mediators.